Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Avilar Therapeutics Logo
Avilar Therapeutics Growth Score
48
CB Rank
38205
Heat Score
62
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Founded
obfuscation
PrivateSeed Waltham, Massachusetts, United States11-50 www.avilar-tx.com/
Biotechnology
Medical
Pharmaceutical
Overview

Avilar Therapeutics
Total Funding
obfuscation
Growth Score
48
Heat Score
62

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score48
-6 pts
in past quarter
Heat Score 62
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Avilar Therapeutics

CB Rank
38205
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Founded
obfuscation
PrivateSeed Waltham, Massachusetts, United States11-50 www.avilar-tx.com/
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Avilar Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Daniel Grau, Milind Deshpande
About the Company
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

ATAC Platform
A platform for designing bifunctional molecules that target extracellular proteins for degradation via the ASGPR-mediated endolysosomal pathway.
MTAC Platform
A platform for extracellular protein degradation using M6PR-targeting chimeras to expand the range of degradable proteins beyond ATAC technology.

Research & Development

Avilar Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed
obfuscation
Seed Round - Avilar Therapeutics Logo
Seed Round - Avilar Therapeutics
4
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Board Members and Advisors 3 Contacts 13

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 3, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 2, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,125
76.06%
 in past month

IT Spend

$230KThis year, Avilar Therapeutics is projected to spend $230K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
iCloud Logo
iCloud
86
Gmail Logo
Gmail
84
Email List Management Logo
Email List Management
84

Active Website Tech Count

26Avilar Therapeutics is actively using 26 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Avilar Therapeutics's headquarters? Avilar Therapeutics is located in Waltham, Massachusetts, United States.Who invested in Avilar Therapeutics? Avilar Therapeutics has 4 investors including Medical Excellence Capital and  Astellas Venture Management.When was the last funding round for Avilar Therapeutics? Avilar Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Avilar Therapeutics's competitors? Alternatives and possible competitors to Avilar Therapeutics may include Lycia Therapeutics, Janux Therapeutics, and  Morphic Therapeutic.How much funding has Avilar Therapeutics raised to date? Avilar Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|